Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
Avtorji:Hofman, Paul (Avtor)
Ilié, M. (Avtor)
Chamorey, E. (Avtor)
Brest, P. (Avtor)
Schiappa, R. (Avtor)
Nakache, V. (Avtor)
Antoine, M. (Avtor)
Barberis, M. (Avtor)
Begueret, H. (Avtor)
Bibeau, F. (Avtor)
Kern, Izidor (Avtor)
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Background: This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. Materials and methods: A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID- 19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. Results: Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. Conclusions: The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe.
Ključne besede:covid-19, pathology, safety, lung neoplasms, biosafety, lung cancer
Leto izida:2020
Založnik:Elsevier
Izvor:Velika Britanija
UDK:616.9
ISSN pri članku:2059-7029
OceCobissID:3924453 Povezava se odpre v novem oknu
COBISS_ID:46351107 Povezava se odpre v novem oknu
DOI:10.1016/j.esmoop.2020.100024 Povezava se odpre v novem oknu
Opombe:Nasl. z nasl. zaslona; Soavtor iz Slovenije: Izidor Kern; Opis vira z dne 11. 1. 2021;
Število ogledov:90
Število prenosov:143
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (665,44 KB)
 
Nadgradivo:ESMO open
BMJ
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:© 2020 The Authors
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:02.12.2020

Nazaj